EUVIMEDEUVIMED entdecken
Crossref

INVESTIGATING CROSS-SPECIES ACTIVITY AND REGULATION OF APOBEC3A

Margo Coxon

Washington State University · 01.01.2024

DOI: 10.7273/000007035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Washington State University, erschienen am 01.01.2024. Verfasst von Margo Coxon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA damage within our cells can be caused by endogenous and exogenous sources. When these lesions are not accurately repaired, it can lead to permanent DNA changes in the form of mutations. Over time an accumulation of mutations, especially those within tumor suppressor genes and proto-oncogenes in a cell’s DNA can lead to the development of cancer and additional mutations that result in metastases and therapeutic resistance. Off-target APOBEC cytidine deaminase activity on genomic DNA is a common endogenous source of mutations in cancer cells. APOBEC3 genes primarily function in the restriction of viral replication, however APOBEC-induced signature mutations, characterized by C-to-T or C-to-G mutations within TCA and TCT sequences, are found in over 50% of sequenced tumor samples across multiple cancer types. Of the 11 APOBECs, APOBEC3A (A3A) has been identified as the main contributor to APOBEC mutations.

Schlagwörter

APOBEC3AAPOBEC cytidine deaminasesAPOBEC mutational signatureDNA damageendogenous mutagenesiscancer mutationstumor suppressorproto-oncogenesviral restrictioncancer therapy resistance

Zitieren

APA

Coxon, M. (2024). INVESTIGATING CROSS-SPECIES ACTIVITY AND REGULATION OF APOBEC3A. Washington State University. https://doi.org/10.7273/000007035

Vancouver

Coxon M. INVESTIGATING CROSS-SPECIES ACTIVITY AND REGULATION OF APOBEC3A. Washington State University. 2024. doi:10.7273/000007035

BibTeX
@article{Coxon2024,
  author = {Coxon, Margo},
  title = {INVESTIGATING CROSS-SPECIES ACTIVITY AND REGULATION OF APOBEC3A},
  journal = {Washington State University},
  year = {2024},
  doi = {10.7273/000007035}
}
Kostenlos starten →